RedHill Biopharma (RDHL) Short Interest Ratio & Short Volume → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free RDHL Stock Alerts $0.45 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media RedHill Biopharma Short Interest DataCurrent Short Volume741,500 sharesPrevious Short Volume906,900 sharesChange Vs. Previous Month-18.24%Dollar Volume Sold Short$299,640.15Short Interest Ratio / Days to Cover0.6Last Record DateApril 15, 2024Outstanding Shares29,703,000 sharesFloat Size29,550,000 sharesShort Percent of Float2.51%Today's Trading Volume173,876 sharesAverage Trading Volume1,034,182 sharesToday's Volume Vs. Average17% Short Selling RedHill Biopharma ? Sign up to receive the latest short interest report for RedHill Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRDHL Short Interest Over TimeRDHL Days to Cover Over TimeRDHL Percentage of Float Shorted Over Time Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report RedHill Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024741,500 shares $299,640.15 -18.2%2.5%0.6 $0.40 3/31/2024906,900 shares $480,566.31 -14.4%3.1%0.7 $0.53 3/15/20241,060,000 shares $558,408.00 +181.8%3.6%0.8 $0.53 2/29/2024376,200 shares $231,363.00 -38.9%1.3%0.2 $0.62 2/15/2024615,700 shares $334,756.09 -44.5%2.1%0.1 $0.54 1/31/20241,110,000 shares $643,800.00 +263.1%3.8%0.1 $0.58 Get the Latest News and Ratings for RDHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RedHill Biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024305,700 shares $324,042.00 -57.5%1.6%0 $1.06 12/31/2023720,000 shares $1.05 million +149.3%3.7%0.1 $1.46 12/15/2023288,800 shares $329,232.00 -93.9%1.5%0 $1.14 11/30/20234,740,000 shares $9.48 million +16,188.7%24.2%0.5 $2.00 11/15/202329,100 shares $9,748.50 -90.1%0.3%0 $0.34 10/31/2023293,600 shares $129,184.00 +153.1%2.7%0.2 $0.44 10/15/2023116,000 shares $37,120.00 +590.5%1.1%0.1 $0.32 9/30/202316,800 shares $8,568.00 +200.0%0.3%0 $0.51 9/15/20235,600 shares $4,760.00 -27.3%0.1%0 $0.85 8/31/20237,700 shares $6,768.30 +102.6%0.1%0 $0.88 8/15/20233,800 shares $3,156.66 -85.7%0.1%0 $0.83 7/31/202326,600 shares $34,048.00 -77.7%0.5%0.1 $1.28 7/15/2023119,400 shares $213,726.00 +594.2%4.1%0.6 $1.79 6/30/202317,200 shares $20,640.00 -39.0%0.6%0.1 $1.20 6/15/202328,200 shares $54,990.00 -64.5%1.0%0.3 $1.95 5/31/202379,400 shares $184,208.00 -31.9%2.7%0.8 $2.32 5/15/2023116,600 shares $267,014.00 -31.7%4.0%1.2 $2.29 4/30/2023170,700 shares $414,801.00 +9.4%6.4%1.6 $2.43 4/15/2023156,100 shares $501,081.00 +25.6%5.8%1 $3.21 3/31/2023124,300 shares $508,387.00 -11.7%5.1%0.8 $4.09 3/15/2023140,800 shares $1.01 million -97.8%N/A0.9 $7.16 2/28/20236,410,000 shares $1.45 million -3.0%N/A1.1 $0.23 2/15/20236,610,000 shares $1.41 million -18.5%N/A1.1 $0.21 1/31/20238,110,000 shares $1.77 million +279.0%N/A1.4 $0.22 1/15/20232,140,000 shares $422,650.00 +22.3%N/A0.7 $0.20 12/30/20221,750,000 shares $245,525.00 +32.6%N/A0.4 $0.14 12/15/20221,320,000 shares $252,120.00 -47.6%N/A0.4 $0.19 11/30/20222,520,000 shares $907,200.00 +22.3%N/A0.8 $0.36 11/15/20222,060,000 shares $1.13 million -14.9%N/A0.7 $0.55 10/31/20222,420,000 shares $1.68 million -8.0%N/A0.9 $0.70 10/15/20222,630,000 shares $1.36 million -1.1%N/A0.9 $0.52 9/30/20222,660,000 shares $1.34 million +60.2%N/A1.8 $0.50 9/15/20221,660,000 shares $1.32 million No ChangeN/A0.7 $0.80 8/31/20221,660,000 shares $1.49 million +4.4%N/A0.5 $0.90Gold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. RDHL Short Interest - Frequently Asked Questions What is RedHill Biopharma's current short interest? Short interest is the volume of RedHill Biopharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 741,500 shares of RDHL short. 2.51% of RedHill Biopharma's shares are currently sold short. Learn More on RedHill Biopharma's current short interest. What is a good short interest ratio for RedHill Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RDHL shares currently have a short interest ratio of 1.0. Learn More on RedHill Biopharma's short interest ratio. What is a good short interest percentage for RedHill Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.51% of RedHill Biopharma's floating shares are currently sold short. Is RedHill Biopharma's short interest increasing or decreasing? RedHill Biopharma saw a drop in short interest in April. As of April 15th, there was short interest totaling 741,500 shares, a drop of 18.2% from the previous total of 906,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is RedHill Biopharma's float size? RedHill Biopharma currently has issued a total of 29,703,000 shares. Some of RedHill Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. RedHill Biopharma currently has a public float of 29,550,000 shares. How does RedHill Biopharma's short interest compare to its competitors? 2.51% of RedHill Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to RedHill Biopharma: MIRA Pharmaceuticals, Inc. (0.43%), Purple Biotech Ltd (0.93%), ABVC BioPharma, Inc. (6.14%), Imunon, Inc. (4.96%), Kiora Pharmaceuticals, Inc. (0.31%), Akari Therapeutics, Plc (0.01%), Elevai Labs, Inc. (0.32%), Monopar Therapeutics Inc. (2.01%), Edesa Biotech, Inc. (0.65%), Moleculin Biotech, Inc. (1.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short RedHill Biopharma stock? Short selling RDHL is an investing strategy that aims to generate trading profit from RedHill Biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against RedHill Biopharma? A short squeeze for RedHill Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RDHL, which in turn drives the price of the stock up even further. How often is RedHill Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RDHL, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: MIRA Pharmaceuticals Short Interest Data Purple Biotech Short Interest Data ABVC BioPharma Short Interest Data Imunon Short Interest Data Kiora Pharmaceuticals Short Interest Data Akari Therapeutics Short Interest Data Elevai Labs Short Interest Data Monopar Therapeutics Short Interest Data Edesa Biotech Short Interest Data Moleculin Biotech Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RDHL) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGold ManiaStansberry ResearchThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap Profits